Hyafilia ME:DAM Prime

Hyafilia is a new generation of fillers from the South Korean company CHA Meditech Co., Ltd. The company has developed a structure of hyaluronic acid that combines the best qualities of monophasic and biphasic fillers. So the composition contains 85% of the stabilized substance and 15% of the native. The series is represented by Hyafilia Classic, Hyafilia Grand, Hyafilia Petit.

Show More

• Description

HyaFilia ME:DAM are fillers of the 5th generation hybrid structure. They combined the best qualities of both mono-and biphasic products. HyaFilia ME:DAM is manufactured by Low Temperature Stabilization Reaction process. This process enabled manufacturing of hyaluronic acid gel with high density and finely packed molecular structure. This process enabled manufacturing of hyaluronic acid gel with high density and finely packed molecular structure. As the result, product is equipped with high resilience and enzyme resistance.

Benefits of Hyafilia ME:DAM Prime:

• non-animal origin (does not require allergo tests before the procedure) and biodegradable
• high elasticity of filler
• two-stage hyaluronic acid purification process (less residual BDDE)
• low injection force enables to inject filler with lesser efforts and prevent edema and bruises after the procedure

Scope of Hyafilia ME:DAM Prime

• correction of medium and deep wrinkles
• correction of nasolabial folds
• "puppet lines"
• lip augmentation
• hands correction

Aesthetic effect lasts up to 9 months.

Product composition: Cross-linked HA 20 mg / ml

Hyafilia ME:DAM Prime

1 syringe × 1.0 ml per pack

Manufacturer: CHA Meditech Co., Ltd., South Korea

The product has contraindications. We are not responsible for any negative effects that you may encounter after administering products by yourself. It is recommended to consult a doctor or medical professional for any procedure.